DEF 14A
XBRL
DEF 14A
- Company
- Matinas BioPharma Holdings, Inc.
- Filed
- May 12, 2025
- Period of Report
- May 12, 2025
- Accession Number
- 0001641172-25-009754
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →